INDOUS · Indo Us Biotech Limited · Financials
Market Cap
1.31B INR
Shares
20.05M
Volume · Nov 13
2582
Avg daily vol (3M)
18.56K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
1.1B
+6.4%
FY2026
Net Income
131.23M
-19.3%
FY2026
Operating Cash Flow
-160.86M
-1034.8%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 |
|---|---|---|---|
| INR | 968.56M | 1.1B | 1.04B |
| INR | 10.45M | 9.02M | 10.98M |
| INR | 29.23M | 22.43M | 14.88M |
| INR | 49.71M | 139.2M | 165.31M |
| INR | 6.37M | 7.97M | 2.63M |
| INR | 43.34M | 131.23M | 162.67M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 5.01M in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.